Activation of the p53-dependent G1 checkpoint response in mouse embryo fibroblasts depends on the specific DNA damage inducer

Oncogene

Volumn 23, Issue 4, 2004, Pages 973-980

  Attardi, Laura D ^a   De Vries, Annemieke ^b   Jacks, Tyler ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Apoptosis; Cell cycle arrest; Chemotherapeutics; DNA damage; p53

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; PROTEIN P21; PROTEIN P53; PYRIMIDINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; DRUG MECHANISM; EMBRYO; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; ULTRAVIOLET C RADIATION;

ADENOVIRUS E1A PROTEINS; ANIMALS; DNA DAMAGE; EMBRYO; FIBROBLASTS; G1 PHASE; MICE; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

ANIMALIA;

EID: 1342343921     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207026     Document Type: Article

References (22)

1. Appella E and Anderson CW. (2001). Eur. J. Biochem., 268, 2764-2772.
2. Attardi LD, Reczek EE, Cosmas C, Demicco EG, McCurrach ME, Lowe SW and Jacks T. (2000). Genes Dev., 14, 704-718.
3. Bargonetti J and Manfredi JJ. (2002). Curr. Opin. Oncol., 14, 86-91.
4. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T and Hannon GJ. (1995). Nature, 377, 552-557.
5. Chang D, Chen F, Zhang F, McKay BC and Ljungman M. (1999). Cell Growth Differ., 10, 155-162.
6. Deng C, Zhang P, Harper JW, Elledge SJ and Leder P. (1995). Cell 82, 675-684.
7. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817-825.
8. Johnstone RW, Ruefli AA and Lowe SW. (2002). Cell, 108, 153-164.
9. Kapoor M and Lozano G. (1998). Proc. Natl. Acad Sci. USA, 95, 2834-2837.
10. Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace Jr AJ. (1992). Cell, 71, 587-597.
11. Lowe SW, Ruley HE, Jacks T and Housman DE. (1993). Cell, 74, 957-967.
12. Lu H, Taya Y, Ikeda M and Levine AJ. (1998). Proc. Natl. Acad. Sci. USA, 95, 6399-6402.
13. Nelson WG and Kastan MB. (1994). Mol. Cell. Biol., 14, 1815-1823.
14. O'Dwyer PJ, Johnson SW and Hamilton TC. (1997). Principles and Practice of Oncology. DeVita Jr V, Hellman S and Rosenberg SA (eds). Lippincott-Raven: Philadelphia, pp. 419-432.
15. Pines J. (1994). Nature, 369, 520-521.
16. Soengas MS, Alarcon RM, Yoshida H, Giaccia AJ, Hakem R, Mak TW and Lowe SW. (1999). Science, 284, 156-159.
17. Stewart CF and Ratain MJ. (1997). Principles and Practice of Oncology. DeVita Jr V, Hellman S and Rosenberg SA (eds). Lippincott-Raven: Philadelphia, pp. 452-467.
18. Tang D, Wu D, Hirao A, Lahti JM, Liu L, Mazza B, Kidd VJ, Mak TW and Ingram AJ. (2002). J. Biol Chem., 277, 12710-12717.
19. Wahl GM and Carr AM. (2001). Nat. Cell. Biol., 3, E277-E286.
20. Waldman T, Kinzler KW and Vogelstein B. (1995). Cancer Res., 55, 5187-5190.
21. Zamble DB, Jacks T and Lippard SJ. (1998). Proc. Natl. Acad. Sci. USA, 95, 6163-6168.
22. Zhou BB and Elledge SJ. (2000). Nature, 408, 433-439.